222 related articles for article (PubMed ID: 3417233)
1. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
Chen PJ; Chen DS; Chen CR; Chen YY; Chen HM; Lai MY; Sung JL
Hepatology; 1988; 8(5):1121-4. PubMed ID: 3417233
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B and D virus infection among drug abusers in Taiwan.
Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
[TBL] [Abstract][Full Text] [Related]
3. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
Chen DS; Lai MY; Lee SC; Yang PM; Sheu JC; Sung JL
J Med Virol; 1986 May; 19(1):87-94. PubMed ID: 3701304
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
[TBL] [Abstract][Full Text] [Related]
5. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
Hadziyannis SJ; Sherman M; Lieberman HM; Shafritz DA
Hepatology; 1985; 5(4):544-7. PubMed ID: 4018727
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis B. Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum.
Lindh G
Scand J Infect Dis Suppl; 1986; 50():1-45. PubMed ID: 3468608
[TBL] [Abstract][Full Text] [Related]
7. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers.
Lin HH; Chen PJ; Chen DS; Sung JL; Yang KH; Young YC; Liou YS; Chen YP; Lee TY
J Med Virol; 1989 Sep; 29(1):1-6. PubMed ID: 2584955
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
Lee SD; Wang JY; Wu JC; Tsai YT; Lo KJ; Lai KH; Tsay SH; Govindarajan S
Scand J Infect Dis; 1987; 19(2):173-7. PubMed ID: 3616486
[TBL] [Abstract][Full Text] [Related]
11. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
12. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan.
Chen CJ; Tseng SF; Lu CF; Lin HC; You SL; Chen CS; Hwang SJ; Hsieh SF; Hsu ST
J Med Virol; 1992 Oct; 38(2):97-101. PubMed ID: 1460460
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hepatitis D virus (delta) infection in Melbourne over a 15-year period.
Dimitrakakis M; Waters MJ; Wootton AL; Gust ID
Med J Aust; 1986 Aug 4-18; 145(3-4):128-30. PubMed ID: 3736476
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis delta in HIV-infected individuals in Europe.
Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
[TBL] [Abstract][Full Text] [Related]
15. Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis.
Jenhani F; Ayed K; Gorgi Y; Zoulim F; Pichoud C; Trepo C
Ann Trop Med Parasitol; 1990 Aug; 84(4):349-53. PubMed ID: 2260899
[TBL] [Abstract][Full Text] [Related]
16. Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).
Guan R; Yap I; Wong L; Tan LH; Oon CJ; Wee A
Ann Acad Med Singap; 1989 Jan; 18(1):8-11. PubMed ID: 2540692
[TBL] [Abstract][Full Text] [Related]
17. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
[TBL] [Abstract][Full Text] [Related]
18. Delta-infection and suppression of hepatitis B virus replication in chronic HBsAg carriers.
Krogsgaard K; Kryger P; Aldershvile J; Andersson P; Sørensen TI; Nielsen JO
Hepatology; 1987; 7(1):42-5. PubMed ID: 3804204
[TBL] [Abstract][Full Text] [Related]
19. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.
Pol S; Wesenfelder L; Dubois F; Roingeard P; Carnot F; Driss F; Brechot C; Goudeau A; Berthelot P
J Viral Hepat; 1994; 1(2):131-7. PubMed ID: 8790568
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the transcripts of hepatitis D and B viruses in infected human livers.
Chen PJ; Yang PM; Chen CR; Chen DS
J Infect Dis; 1989 Dec; 160(6):944-7. PubMed ID: 2584763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
